ArticleNEJM catalyst innovations in care delivery2022
A New Technology-Enabled Care Model for Pediatric Type 1 Diabetes.
Article in NEJM catalyst innovations in care delivery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 24 citations in OpenAlex.
- Smart Start - Designing Powerful Clinical Trials Using Pilot Study Data.NEJM evidence · 2024Trial
- Determinants, implementation strategies, and mechanisms of the 4T Program.Journal of clinical & translational endocrinology · 2026Article
- A Quantitative Framework for Evaluating the Performance of Algorithm-Directed Whole-Population Remote Patient Monitoring: Tutorial for Type 1 Diabetes Care.JMIR diabetes · 2026Article
- Insights and Advances in Physical Activity Research on Youth with Type 1 Diabetes.Current diabetes reports · 2026Review
- Establishment of a Diabetes-Tailored Data Intelligence Platform Enhances Clinical Care, Enables Risk-Based Monitoring, and Facilitates Population-Health-Based Approaches at a Pediatric Diabetes Network.Journal of diabetes science and technology · 2025Article
- Caregiver experiences of an integrative patient-centered digital health application for pediatric type 1 diabetes care: Findings from a pilot clinical trial.PLOS digital health · 2025Article
- Preventing Urgent Pediatric Readmissions: The Need for and Promise of Real-Time Monitoring.JMIR pediatrics and parenting · 2025Article
- The adaptation of a single institution diabetes care platform into a nationally available turnkey solution.NPJ digital medicine · 2024Article
- Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes.Nature medicine · 2024Article
- Role and Perspective of Certified Diabetes Care and Education Specialists in the Development of the 4T Program.Diabetes spectrum : a publication of the American Diabetes Association · 2024Article
- A quantitative model to ensure capacity sufficient for timely access to care in a remote patient monitoring program.Endocrinology, diabetes & metabolism · 2023Article
- Roadmap to Continuous Glucose Monitoring Adoption and Improved Outcomes in Endocrinology: The 4T (Teamwork, Targets, Technology, and Tight Control) Program.Diabetes spectrum : a publication of the American Diabetes Association · 2023Article
- The evolving role of data & safety monitoring boards for real-world clinical trials.Journal of clinical and translational science · 2023Article
- 'Much more convenient, just as effective': Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis.Diabetic medicine : a journal of the British Diabetic Association · 2022Article
- Advancements and future directions in the teamwork, targets, technology, and tight control-the 4T study: improving clinical outcomes in newly diagnosed pediatric type 1 diabetes.Current opinion in pediatrics · 2022Review
- Adding glycemic and physical activity metrics to a multimodal algorithm-enabled decision-support tool for type 1 diabetes care: Keys to implementation and opportunities.Frontiers in endocrinology · 2022Article
- A model to design financially sustainable algorithm-enabled remote patient monitoring for pediatric type 1 diabetes care.Frontiers in endocrinology · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
In July 2018, pediatric type 1 diabetes (T1D) care at Stanford suffered many of the problems that plague U.S. health care. Patient outcomes lagged behind those of peer European nations, care was delivered primarily on a fixed cadence rather than as needed, continuous glucose monitors (CGMs) were largely unavailable for individuals with public insurance, and providers' primary access to CGM data was through long printouts. Stanford developed a new technology-enabled, telemedicine-based care model for patients with newly diagnosed T1D. They developed and deployed Timely Interventions for Diabetes Excellence (TIDE) to facilitate as-needed patient contact with the partially automated analysis of CGM data and used philanthropic funding to facilitate full access to CGM technology for publicly insured patients, for whom CGM is not readily available in California. A study of the use of CGM for patients with new-onset T1D (pilot Teamwork, Targets, and Technology for Tight Control [4T] study), which incorporated the use of TIDE, was associated with a 0.5%-point reduction in hemoglobin A1c compared with historical controls and an 86% reduction in screen time for providers reviewing patient data. Based on this initial success, Stanford expanded the use of TIDE to a total of 300 patients, including many outside the pilot 4T study, and made TIDE freely available as open-source software. Next steps include expanding the use of TIDE to support the care of approximately 1,000 patients, improving TIDE and the associated workflows to scale their use to more patients, incorporating data from additional sensors, and partnering with other institutions to facilitate their deployment of this care model.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.